Features of Cross-Seeding of Wild-Type Alpha-Synuclein and Its Mutant Form A53T Potentially Useful for the Development of Test Systems
Since the features of cross-seeding of alpha-synuclein forms may affect the sensitivity and specificity of the test systems, we developed a modified approach to obtain alpha-synuclein amyloid seeds with particle sizes from 20 to 50 nm prepared from either the wild-type protein (α-synWT) or its more fibrillation-prone form A53T (α-synA53T). These seeds had optimal properties for subsequent initiation of fibrillation. Our data showed that the elevated efficiency of alpha-synuclein A53T monomer transformation was hardly affected by the type of used seeds, whereas the addition of the seeds obtained from the alpha-synuclein mutant form to wild-type protein monomers had a significantly smaller effect than α-synWT seeds. Transmission electron microscopy data revealed that in the presence of α-synWT seeds the wild-type alpha-synuclein formed long and wide fibrils, while the addition of α-synA53T seeds led to the formation of long, but thin fibrils. Since the lag period of α-synA53T monomer fibrillation was significantly reduced compared to the wild-type protein, the replacing of α-synWT with α-synA53T in current assay systems designed to detect aberrant forms of α-synuclein in biological fluid samples (e.g., RT-QuIC) could substantially cut the time of analysis. In the future, a set of alpha-synuclein mutant forms could be used for the differential diagnosis of synucleinopathies caused by the different mutations of this protein.
Authors
- Kseniya Barinova
- Nataliya Kolotyeva
- Sergei Illarioshkin
- Vladimir Muronetz
- Michail Piradov
- Lidia Kurochkina (ORCID: https://orcid.org/0000-0002-1030-0037)
- Sofiya Kudryavtseva (ORCID: https://orcid.org/0000-0001-7549-607X)
- Sergei Golyshev (ORCID: https://orcid.org/0000-0002-4877-1061)
Institutions
- Lomonosov Moscow State University (RU)
- Center for Neurosciences (US)
- Research Center of Neurology (RU)
Publication Details
- Journal
- Life
- Published
- 2026-04-15
- DOI
- https://doi.org/10.3390/life16040675
- Primary Topic
- Parkinson's Disease Mechanisms and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Ministry of Science and Higher Education of the Russian Federation